LANCET INFECTIOUS DISEASES

Scope & Guideline

Bridging Research and Practice in Infectious Diseases

Introduction

Delve into the academic richness of LANCET INFECTIOUS DISEASES with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN1473-3099
PublisherELSEVIER SCI LTD
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 2001 to 2024
AbbreviationLANCET INFECT DIS / Lancet Infect. Dis.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address125 London Wall, London EC2Y 5AS, ENGLAND

Aims and Scopes

The Lancet Infectious Diseases is a leading journal that focuses on the global burden of infectious diseases, their epidemiology, prevention, and treatment. The journal aims to disseminate high-quality research that informs clinical practice, policy-making, and public health responses to emerging and re-emerging infectious diseases.
  1. Infectious Disease Epidemiology:
    The journal emphasizes research on the epidemiology of various infectious diseases, including the dynamics of disease transmission, outbreak investigations, and the impact of social determinants on disease spread.
  2. Clinical Trials and Treatment Innovations:
    It publishes studies on clinical trials evaluating new treatments, vaccines, and preventive strategies for infectious diseases, highlighting the efficacy and safety of novel therapeutic approaches.
  3. Public Health and Policy:
    The journal explores the implications of research findings for public health policy, including vaccination strategies, antimicrobial stewardship, and health system responses to epidemics and pandemics.
  4. Global Health Perspectives:
    It addresses the global burden of infectious diseases, with a focus on low- and middle-income countries, discussing challenges and successes in disease control and health equity.
  5. Emerging Infectious Diseases:
    The journal covers research on emerging and re-emerging infectious diseases, including zoonotic diseases, highlighting the need for continuous surveillance and rapid response mechanisms.
The Lancet Infectious Diseases has seen significant trends and emerging themes in its recent publications, reflecting current global health priorities and the evolving landscape of infectious diseases.
  1. COVID-19 Research and Vaccination Strategies:
    A substantial increase in publications related to COVID-19, including vaccine efficacy, long-term effects, and public health responses, has been observed as the pandemic continues to influence global health.
  2. Innovative Treatment Approaches:
    Emerging themes in novel treatment strategies utilizing monoclonal antibodies, antiviral therapies, and combination therapies for various infectious diseases are gaining prominence.
  3. Global Health Security and Preparedness:
    Research focusing on pandemic preparedness, surveillance systems, and global health security has surged, emphasizing the importance of readiness for future outbreaks.
  4. Mental Health and Infectious Diseases:
    There is a growing trend in exploring the intersection of mental health and infectious diseases, particularly in the context of the COVID-19 pandemic and its psychological impacts.
  5. Antimicrobial Stewardship and Resistance Management:
    Increased attention is being paid to antimicrobial stewardship programs and strategies to combat resistance, reflecting an ongoing commitment to addressing AMR as a public health threat.

Declining or Waning

While The Lancet Infectious Diseases continues to cover a wide range of infectious diseases, certain themes have seen a decline in prominence over recent years. This may reflect shifts in global health priorities or emerging challenges that require more immediate attention.
  1. Antimicrobial Resistance (AMR):
    Although AMR remains a critical issue, the frequency of dedicated publications on AMR has decreased, possibly due to the heightened focus on COVID-19-related research and other emerging infectious diseases.
  2. Tuberculosis (TB) Research:
    There has been a noticeable reduction in the number of studies specifically addressing tuberculosis, particularly in the context of treatment regimens and epidemiological studies, as other infectious diseases have gained more attention.
  3. Neglected Tropical Diseases (NTDs):
    Research focused on NTDs has waned, potentially overshadowed by more pressing global health crises such as COVID-19, leading to fewer dedicated articles on these diseases.
  4. Vaccine Development for Established Diseases:
    The journal has shifted focus towards COVID-19 vaccine research, resulting in fewer publications on vaccines for diseases like measles, mumps, and rubella, which were previously more prominently discussed.
  5. Longitudinal Studies on Historical Diseases:
    There has been a decline in the publication of longitudinal studies tracking historical infectious diseases, as newer outbreaks and emerging pathogens dominate the research landscape.

Similar Journals

EMERGING INFECTIOUS DISEASES

Empowering Researchers to Tackle Emerging Diseases
Publisher: CENTERS DISEASE CONTROL & PREVENTIONISSN: 1080-6040Frequency: 12 issues/year

Emerging Infectious Diseases, published by the Centers for Disease Control and Prevention, is a leading open-access journal that has been dedicated to the field of epidemiology, infectious diseases, and medical microbiology since its inception in 1995. With an impressive impact factor placing it in the Q1 quartile rankings for multiple categories including Epidemiology, Infectious Diseases, and Medical Microbiology, this journal serves as a vital resource for researchers, practitioners, and students dedicated to combating the challenges posed by emerging infectious diseases. The journal's distinguished Scopus ranks further highlight its global influence, ranking #10 in Epidemiology, #26 in Infectious Diseases, and #13 in Medical Microbiology, all within the top percentiles. Accessible and targeted, Emerging Infectious Diseases publishes seminal research and reviews that contribute to the understanding and management of infectious diseases, ensuring that critical insights reach a broad audience. The journal encourages contributions that advance the scientific community’s knowledge and responses to public health challenges.

Brazilian Journal of Infectious Diseases

Fostering collaboration for impactful health solutions.
Publisher: ELSEVIER BRAZILISSN: 1413-8670Frequency: 6 issues/year

The Brazilian Journal of Infectious Diseases, published by Elsevier Brazil, is a premier open-access journal dedicated to advancing research and clinical practice in the field of infectious diseases. Since its inception in 2001, this journal has been pivotal in disseminating innovative studies and reviews that inform healthcare professionals and researchers alike. With an impressive impact factor reflected by its ranking in the second quartile for Infectious Diseases and third quartile for Medical Microbiology in 2023, the journal ranks #127 out of 344 in medicine – infectious diseases and #61 out of 140 in medical microbiology, showcasing its reputable standing in the scientific community. The Brazilian Journal of Infectious Diseases invites contributions that highlight significant findings, novel methodologies, and critical reviews aimed at enhancing patient care and public health initiatives. With an international readership and a focus on pressing issues in infectious diseases, it serves as an essential platform for knowledge exchange and collaboration among scholars and practitioners across Brazil and beyond. By reinforcing the importance of open access to scientific literature, this journal not only promotes transparency but also enhances the global discourse surrounding infectious diseases.

Tropical Medicine and Infectious Disease

Exploring the frontiers of infectious disease research.
Publisher: MDPIISSN: Frequency: 12 issues/year

Tropical Medicine and Infectious Disease, published by MDPI, is a leading peer-reviewed journal dedicated to advancing the field of tropical medicine and infectious diseases. With an open access model established since 2016, this journal fosters a collaborative environment for researchers, professionals, and students from around the world to disseminate cutting-edge findings and innovative approaches to public health challenges, particularly in tropical regions. The journal has earned recognition, achieving a Q2 quartile ranking in notable fields including Immunology and Microbiology, Infectious Diseases, and Public Health, Environmental, and Occupational Health in 2023, indicative of its influence and relevance in the scientific community. With a focus on high-quality research, Tropical Medicine and Infectious Disease aims to bridge the gap between basic science and clinical application, providing invaluable insights critical for combating infectious diseases and improving health outcomes in vulnerable populations. The journal’s accessibility and substantial indexing in major databases further solidify its importance as a key platform for impactful research in this essential field.

Infectious Microbes & Diseases

Unraveling the complexities of microbes and their impact.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: Frequency: 4 issues/year

Infectious Microbes & Diseases, published by Lippincott Williams & Wilkins, is a premier journal dedicated to the exploration and understanding of infectious diseases, microbiology, and epidemiology. With its focused scope and robust peer-review process, the journal aims to disseminate high-quality research that contributes to advancements in the field, making it an essential resource for researchers, healthcare professionals, and students alike. Established in 2019, it has quickly gained recognition, achieving a Q3 rating in categories such as Epidemiology, Infectious Diseases, and Medical Microbiology in 2023, and ranking in the top half of its field within Scopus metrics. Although currently offered as a subscription-based journal, Infectious Microbes & Diseases significantly enriches its disciplines by inviting innovative research and critical review articles, thus playing a vital role in combating the global challenges posed by infectious diseases.

EPIDEMIOLOGY AND INFECTION

Unveiling Trends in Epidemiology and Infection
Publisher: CAMBRIDGE UNIV PRESSISSN: 0950-2688Frequency: 1 issue/year

EPIDEMIOLOGY AND INFECTION is a premier open-access journal published by Cambridge University Press, dedicated to advancing the field of epidemiology and infectious diseases. With an ISSN of 0950-2688 and E-ISSN of 1469-4409, this journal has been at the forefront of disseminating impactful research since its inception in 1970. As of 2023, it holds a prestigious Q2 ranking in both the fields of Epidemiology and Infectious Diseases, reflecting its significant contribution to these critical areas of study, with Scopus rankings placing it at #70 in Epidemiology and #163 in Infectious Diseases. The journal aims to publish high-quality, peer-reviewed studies that contribute to our understanding and management of infectious diseases globally. Operating under an open-access model since 2020, EPIDEMIOLOGY AND INFECTION ensures that research is accessible to a wide audience, fostering collaboration and innovation among researchers, professionals, and students alike. With a commitment to excellence, this journal is an essential resource for those looking to stay abreast of the latest developments in epidemiological research and infectious disease management.

Asia-Pacific Journal of Public Health

Innovating solutions for diverse populations' health needs.
Publisher: SAGE PUBLICATIONS INCISSN: 1010-5395Frequency: 8 issues/year

Asia-Pacific Journal of Public Health, published by SAGE Publications Inc, is a leading platform for disseminating scholarly research in the field of public health. With an impressive scope that spans from the late 1980s to the present, the journal offers a wealth of articles that address critical issues faced by diverse populations in the Asia-Pacific region. Categorized in the Q3 quartile for both Medicine (miscellaneous) and Public Health, Environmental and Occupational Health, it holds a significant position within its field, ranked 310 out of 665 in the Scopus database. Researchers and professionals have access to valuable insights that inform public health policy and practice, making this journal an essential resource for those aiming to enhance health outcomes in the region. While not currently open access, the journal's rigorous peer-review process ensures the integrity and relevance of its content. As the landscape of public health continues to evolve, the Asia-Pacific Journal of Public Health remains a vital resource for advancing knowledge, fostering collaboration, and promoting a healthier society.

Journal of Pathogens

Empowering Researchers in the Fight Against Pathogens
Publisher: HINDAWI LTDISSN: 2090-3057Frequency:

Journal of Pathogens is a premier peer-reviewed journal published by HINDAWI LTD, focusing on the critical field of microbiology, infectious diseases, and the mechanisms of pathogen interactions with hosts. Since its inception in 2011 as an Open Access journal, it has aimed to provide a platform for high-quality research articles, reviews, and case studies that enhance our understanding of pathogenesis and advance the science of disease control. With its commitment to making research freely accessible, the journal attracts a global audience of researchers, professionals, and graduate students keen on exploring innovative findings and applications in the study of pathogens. While the journal does not currently have an established H-index or category quartiles, its relevance and importance in the field continue to grow as it seeks to bridge knowledge gaps and facilitate impactful discussions in infectious disease research. Located at Adam House, 3rd Floor, 1 Fitzroy Square, London W1T 5HF, England, the Journal of Pathogens invites submissions that contribute to the ever-evolving landscape of pathogen research and public health.

China CDC Weekly

Bridging gaps in health knowledge with open-access research.
Publisher: Chinese Center for Disease Control and PreventionISSN: 2096-7071Frequency: 52 issues/year

China CDC Weekly is an esteemed academic journal published by the Chinese Center for Disease Control and Prevention, dedicated to disseminating critical research in the fields of epidemiology, infectious diseases, and public health. Since its inception in 2019, the journal has rapidly established itself as a key resource for scholars, professionals, and students, achieving notable rankings, including Q2 in Epidemiology and Infectious Diseases, and Q1 in Public Health, Environmental, and Occupational Health for 2023. With an emphasis on the latest advancements and data-driven insights, China CDC Weekly offers a platform for researchers to contribute to the vital discourse surrounding health policies, disease control, and public safety in a rapidly evolving global landscape. As an open-access journal, it ensures widespread availability and visibility of research findings, reflecting its commitment to advancing public health knowledge in China and beyond. The conference years from 2019 to 2024 further highlight its responsiveness to emerging health challenges and trends, positioning the journal as a preeminent publication for interdisciplinary collaboration and innovation.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Catalyzing change in global health through research.
Publisher: ELSEVIER SCI LTDISSN: 1201-9712Frequency: 12 issues/year

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, published by ELSEVIER SCI LTD, stands as a leading platform in the realm of infectious diseases, contributing significantly to the global understanding of this critical field. With an impressive impact factor, the journal maintains a distinguished Q1 ranking across various categories, including Infectious Diseases, Medicine (miscellaneous), and Medical Microbiology, demonstrating its high relevance and influence among contemporary research. Since its inception in 1996, it has embraced an Open Access model, allowing for wider dissemination of essential research findings that can inform public health policies and clinical practices. With a commitment to advancing scientific knowledge, this journal is not only a vital resource for researchers and professionals but also serves as an invaluable educational tool for students interested in the complexities of infectious diseases and their management. For those looking to stay at the forefront of research and innovation in this field, the INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES is an indispensable resource.

Open Forum Infectious Diseases

Innovating solutions for evolving health challenges.
Publisher: OXFORD UNIV PRESS INCISSN: 2328-8957Frequency: 12 issues/year

Open Forum Infectious Diseases (ISSN: 2328-8957; E-ISSN: 2328-8957) is a leading open-access journal published by Oxford University Press, dedicated to advancing the field of infectious diseases. Since its inception in 2014, the journal has provided a platform for researchers to disseminate impactful findings in a rapidly evolving domain, achieving a remarkable Q1 ranking in both the Infectious Diseases and Oncology categories as of 2023. The journal encourages rigorous and innovative research, contributing significantly to global health discussions and informing best practices in clinical settings. As an open-access journal, it ensures that its content is accessible to a wide audience, fostering collaboration and knowledge sharing among researchers, professionals, and students alike. Positioned in the heart of the United States, Open Forum Infectious Diseases serves as a critical resource for the academic community, and its continued commitment to quality and relevance secures its status as an essential publication in the field.